Skip to content

About JXN

Our mission is to end preventable harm in long-term care.

Ian in the hospital, after his accident
Our story

Why we started JXN.

In 2018, four days after my 22nd birthday, I was hit by a car. I was a senior studying biomedical engineering, a few months from graduating and less than a year from starting medical school. I spent three weeks in the ICU and trauma unit with a shattered left leg and a broken back, but all I could think about was getting back to class. Still bedridden, I pushed to be transferred to inpatient rehab so I could stay on track for graduation and my dreams of becoming a doctor. Within a week of arriving, I developed a stage 4 bedsore on my heel. It stopped my recovery cold, adding three months and hundreds of thousands of dollars to it, and nearly cost me my leg below the knee.

I finished that semester online, returned the next in a wheelchair, and graduated on time, even managing to walk across the stage to receive my degree. But by then my plans had changed. While I was healing, I learned that bedsores are almost entirely preventable with proper care. If one could happen to me, young, fit, and otherwise healthy, it could happen to anyone, and every day it does. So instead of going to medical school, I started JXN Technologies with my high school friend, Cole. Our mission is to end preventable harm in long-term care by building accessible technology that improves resident outcomes while supporting the teams who care for them, so that the right choice is also the easy one.

Eight years later, with more than a dozen surgeries and counting, I am still living in a body that reminds me every day why our work matters. Every facility that partners with us helps make sure someone else's story never includes the chapter mine did.

Ian Jackson, Founder and CEO

Further reading

University of Arizona EngineeringEngineering Wildcat Back on His Feet With Mentor’s HelpSept. 27, 2019. Ian’s recovery, and why he turned from medical school to improving the patient experience.Published research, PubMedDevelopmental programming: Prenatal testosterone excess disrupts pancreatic islet developmental trajectory in female sheep2020. Peer-reviewed study co-authored by Ian Jackson.

Leadership

Ian Jackson, Founder and CEO

Ian Jackson

Founder and CEO
Cole Stanfield, Co-founder and CTO

Cole Stanfield

Co-founder and CTO
Kerry Jackson, Chief Business Officer

Kerry Jackson

Chief Business Officer

Whether you run a community, have a loved one in care, or just want to understand what we're building, we'd love to hear from you.

Get in touch